SCHEMBL1896161

SCHEMBL1896161

NC(=O)Nc1ncc([N+](=O)[O-])s1

nearest known ligand 0.61

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 8/20 0.61
RAB9A P51151 8/20 0.61
MEN1 O00255 7/20 0.61
KMT2A Q03164 7/20 0.61
LMNA P02545 3/20 0.61
ALDH1A1 P00352 2/20 0.61
MAPT P10636 2/20 0.61
HTT P42858 2/20 0.61
SMN1; SMN2 Q16637 2/20 0.61
ATG4B Q9Y4P1 5/20 0.59
STAT3 P40763 4/20 0.59
PKM P14618 3/20 0.59
POLB P06746 1/20 0.57
CDK2 P24941 1/20 0.56
GSK3A P49840 1/20 0.56
GSK3B P49841 1/20 0.56
DYRK1A Q13627 1/20 0.56
HIPK4 Q8NE63 1/20 0.56
CLK4 Q9HAZ1 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Nithiamide SCHEMBL158858 0.83 NPC1 (0.63) NPC1RAB9AMEN1KMT2ALMNA
SCHEMBL3234255 0.81 ATG4B (0.68) NPC1RAB9AMEN1KMT2ALMNA
SCHEMBL3234242 0.81 ATG4B (0.67) NPC1RAB9AMEN1KMT2ALMNA
SCHEMBL3466003 0.80 LMNA (0.67) NPC1RAB9AMEN1KMT2ALMNA
SCHEMBL881339 0.80 LMNA (0.84) NPC1RAB9AMEN1KMT2ALMNA
SCHEMBL12599400 0.80 NPC1 (0.59) NPC1RAB9AMEN1KMT2ALMNA
SCHEMBL19906418 0.80 ATG4B (0.65) NPC1RAB9AMEN1KMT2ALMNA
SCHEMBL18424530 0.80 ATG4B (0.69) NPC1RAB9AMEN1KMT2ALMNA
SCHEMBL27671732 0.79 NPC1 (0.55) NPC1RAB9AMEN1KMT2ALMNA
SCHEMBL4748802 0.79 ALDH1A1 (0.58) NPC1RAB9AMEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4168536-A1 METHODS AND COMPOSITIONS FOR CULTIVATING PLURIPOTENT CELL SUSPENSIONS Life Technologies Corporation (US) 2023-04-26 EP claimed
WO-2025106671-A1 PERSONALIZED PROGENITOR CELLS IMMORTA BIO, INC. (US) 2025-05-22 WO disclosed
US-20240252688-A1 COMPOSITIONS AND METHODS FOR ENHANCED PROTEIN PRODUCTION HDT BIO CORP. 2024-08-01 US disclosed
EP-4178594-A1 A METHOD FOR GENERATING A THREE-DIMENSIONAL NEUROMUSCULAR ORGANOID IN VITRO Max-Delbrück-Centrum für Molekulare Medizin in der Helmholtz-Gemeinschaft (DE) 2023-05-17 EP disclosed
EP-4153726-A1 METHOD FOR GENERATING FUNCTIONAL SKELETAL MUSCLE FIBERS INNERVATED BY MOTONEURONS Association Française contre les Myopathies (AFM) (FR) 2023-03-29 EP disclosed
CN-104130976-A Generation and maintenance of stem cells SCRIPPS RESEARCH INST 2014-11-05 CN disclosed
CN-102317442-B Production and maintenance of stem cells SCRIPPS RESEARCH INST 2014-08-13 CN disclosed
US-8796182-B2 Genetic markers associated with risk of diabetes mellitus DECODE GENETICS EHF. (IS) 2014-08-05 US disclosed
US-20120220477-A1 GENETIC MARKERS ASSOCIATED WITH RISK OF DIABETES MELLITUS DECODE GENETICS EHF. (IS) 2012-08-30 US disclosed
WO-2011109015-A1 IMPROVED METHODS OF GENERATING PLURIPOTENT STEM CELLS THE SCRIPPS RESEARCH INSTITUTE (US) 2011-09-09 WO disclosed
WO-2011056971-A2 EPISOMAL REPROGRAMMING WITH CHEMICALS CELLULAR DYNAMICS INTERNATIONAL, INC. (US) 2011-05-12 WO disclosed